By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agilis Biotherapeutics 



  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Agilis Biotherapeutics Announces Presentation Of Five Year Follow-Up Data Of Gene Therapy Treatment For AADC Deficiency 5/11/2017 6:23:37 AM
Agilis Biotherapeutics Announces Presentation Of Data From Phase I/II Trial For Treatment Of AADC Deficiency 5/10/2017 6:11:33 AM
Agilis Biotherapeutics Expands Commercial, Medical Teams 5/8/2017 10:23:00 AM
Agilis Biotherapeutics Announces Orphan Designation Approval In Europe For The Treatment Of AADC Deficiency 12/1/2016 8:16:23 AM
Agilis Biotherapeutics Achieves FDA "Rare Pediatric Disease" Designation For AADC Gene Therapy Candidate 11/17/2016 11:24:08 AM
Agilis Biotherapeutics Announces First Patient Treated In Phase IIb Clinical Study Of Gene Therapy For AADC Deficiency 11/16/2016 11:35:30 AM
Agilis Biotherapeutics Announces Authorization Of Phase IIb Clinical Study Of Gene Therapy For AADC Deficiency 10/11/2016 8:48:07 AM
Agilis Biotherapeutics Announces FDA Orphan Drug Designation For The Treatment Of Friedreich’s Ataxia (FA) 8/2/2016 8:55:35 AM
Agilis Biotherapeutics Announces FDA Orphan Drug Designation For The Treatment Of Aromatic L-Amino Acid Decarboxylase Deficiency 6/29/2016 9:29:01 AM
Agilis Biotherapeutics, First Gene Therapy Company Selected For NIH Therapeutics For Rare And Neglected Diseases Program 6/27/2016 10:03:39 AM
1234
//-->